Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 6Rectal Neoplasms 6Colorectal Neoplasms 6Nasopharyngeal Carcinoma 4Nasopharyngeal Neoplasms 3Colonic Neoplasms 3Carcinoma, Squamous Cell 2Pancreatic Neoplasms 1Neoplasms, Squamous Cell 1Neoplasm Metastasis 1Liver Metastases of Colorectal Cancer 1Head and Neck Neoplasms 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1Breast Neoplasms 1Advanced Gastric Cancer Adenocarcinoma of Esophagogastric Junction 1Adenocarcinoma 1

Interventions

Oxaliplatin 1Leucovorin 1Fluorouracil 1Cetuximab 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Liver Metastases of Colorectal Cancer × Fluorouracil × Clear all
NCT06490913 2024-07-08

Chemotherapy Plus EGFR Monoclonal Antibody in Patients With Liver Metastases From Colorectal Cancer With ctDNA Superselective Negative Genes

Fujian Cancer Hospital

Phase 2 Not yet recruiting
33 enrolled
Gastrointestinal

Liver Metastases of Colorectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡